Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study

Sponsor
Malaysia Palm Oil Board (Other)
Overall Status
Completed
CT.gov ID
NCT00715312
Collaborator
(none)
43
1
1
4
10.8

Study Details

Study Description

Brief Summary

Rationale: The effect of positional distribution of dietary fatty acids on markers of inflammation and blood lipids metabolites on diets containing fatty acids such as oleic acid that are associated with reduced risk of cardiovascular disease is not widely studied.

Hypothesis: There would be difference detected in the concentrations of markers of inflammation and blood lipid metabolites in human volunteers fed controlled diets.

Study design: A randomized, double-blind, crossover clinical trial that involves 41 healthy volunteers. The volunteers will be selected based on inclusion and exclusion criteria. They will consume controlled diets for 5 weeks that provides 15% of energy from protein, 30% of energy from fat, and 55% of energy from carbohydrates. Volunteers will be assigned to each test diets which is cooked with novel olein, palm stearin or partially hydrogenated soybean oil in random order until all three diets has consumed by each person.

Main study parameters: LDL-cholesterol

Condition or Disease Intervention/Treatment Phase
  • Other: Novel Olein
  • Other: Novel Olein
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study.
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
Jun 1, 2008
Actual Study Completion Date :
Jun 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

Other: Novel Olein
A total of 70g of test oil is incorporated into cooked meal which accounts for 30-35% of calorie intake

Other: Novel Olein
A total of 70g of test oil is incorporated into cooked meal which provides 30-35% of calorie

Outcome Measures

Primary Outcome Measures

  1. LDL-cholesterol [5 weeks]

Secondary Outcome Measures

  1. C-reactive protein [5 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy and free from any disease and absence of family history for arteriosclerosis or hypertension

  • Not on any medication or supplements or weight loss program

  • Non smokers and alcoholics

Exclusion Criteria:
  • Having some health-related problems e.g fever, flu, allergy, chronic diseases

  • On some treatment or medication

  • Smokers and alcoholics

Contacts and Locations

Locations

Site City State Country Postal Code
1 Malaysia Palm Oil Board Kajang Selangor Malaysia 50720

Sponsors and Collaborators

  • Malaysia Palm Oil Board

Investigators

  • Principal Investigator: Teng Kim Tiu, Malaysia Palm Oil Board

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00715312
Other Study ID Numbers:
  • 625.9
First Posted:
Jul 15, 2008
Last Update Posted:
Jul 15, 2008
Last Verified:
Jul 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2008